ENYO Pharma is a clinical-stage biopharmaceutical company developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function.The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome.
ENYO Pharma is a clinical-stage biopharmaceutical company developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function.The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome.
Ενώ άλλα εργαλεία σπαταλούν χρόνο, εμείς σας βοηθάμε να αξιολογήσετε πιο κατάλληλες εταιρείες μέσα σε λεπτά, ώστε το pipeline σας να παραμένει υγιές, η ομάδα σας παραγωγική και οι συμφωνίες σας να προχωρούν πιο γρήγορα.